The ACR’s SHOP initiative partners pediatric rheumatologists & school nurses to raise cSLE awareness & better support students living with lupus.
Articles by From the College
ACR Advocates for Fair Reimbursement & Telehealth Flexibility in MPFS 2026 Proposed Rule
In comments to the CMS, the ACR advocated for telehealth flexibilities and fair reimbursement and pushed back on proposed efficiency adjustments and changes likely to increase administrative burden on practices.
AMA State Advocacy Roundtable Addresses Pressing Policy Challenges
The roundtable included discussions on emerging issues in state advocacy, prior authorization reform, likely impacts of the Big Beautiful Bill and physician wellness.
ACR Calls on Alaska, Montana to Strengthen Rheumatology Care Through Federal Funding
The new Rural Health Transformation Program offers states the chance to apply for CMS funding aimed at transforming rural healthcare.
What to Expect in Chicago at the Practice Innovation Summit
The Practice Innovation Summit, to be held in Chicago Oct. 24–25, offers a roadmap to a smarter, stronger rheumatology practice, led by experts in operations, coding, financial sustainability and more.
ACR President Warns: Access to Care Is at Risk Without Medicare Payment Reform
In a recent commentary published by Medscape, ACR President Carol Langford, MD, MHS, issues a stark warning: If Congress does not reform the physician payment system, patients may face increasing difficulty accessing essential medical services.
ACR Responds to Threats to Scientific Integrity at the CDC
On Aug. 29, the ACR issued a strong statement expressing deep concern over recent developments at the agency that could threaten the integrity of science-based public health policy.
Why Advocacy Matters: A Call to Action for Rheumatologists
In today’s rapidly evolving healthcare landscape, rheumatologists face a growing number of challenges. Advocacy is a critical tool that helps protect and advance the profession and the patients it serves.
Include Advocacy in Your ACR Convergence 2025 Plans
Check out this quick guide to advocacy events and programming that will help you leave Chicago informed and ready to be an advocate for the rheumatology community back home.
UHC Formulary Change Impacts Coverage for Ustekinumab
Effective Sept. 1, the brand name drug Stelara will no longer be covered on the UnitedHealthcare commercial plan prescription drug list.
- 1
- 2
- 3
- …
- 99
- Next Page »